BACKGROUND: Transfusion of blood products, especilly red blood cells, is one of the most common interventions in daily medical practice and in neonatal units the target population of this intervention is greater than that of other premature risks and with low birth weight. OBJECTIVE: This review will be to generate the most important aspects of the use of erythrocyte package in the neonatal population and the available evidence in this regard. DESCRIPTION: Transfusions of blood products are multiple, especially in the neonatal population, among which include: necrotizing enterocolitis, retinopathy of prematurity, intraventricular hemorrhage, chronic lung disease, among others, so the decision to perform this procedure should be taken considering the indications and possible complications. CONCLUSIONS: New protocols have been developed to minimize the risks associated with this procedure, among which the use of single-donor aliquots is highlighted, to reduce the complications of incompatibility.
|Título traducido de la contribución||Use of erythrocyte package in neonatology: A qualitative review|
|Número de páginas||9|
|Publicación||Acta Pediatrica de Mexico|
|Estado||Publicada - 1 sep. 2018|
|Publicado de forma externa||Sí|
Nota bibliográficaPublisher Copyright:
© 2018 Instituto Nacional de Pediatria. All Rights Reserved.
- Blood products
- Red blood cells